Med-tech firms raising money in public or private financings, including: Bellevue Life Sciences, Current Surgical.

Biopharmas raising money in public or private financings, including: Abilita, Apellis, Azitra, Biomx, Quoin, Sorrento.

Hemab Therapeutics ApS raised $135 million in a series B funding round to continue its broad effort to build a company focused on developing prophylactic therapies for neglected bleeding and thrombotic disorders. The new cash brings its total equity raise to $190 million.

Biopharmas in Asia-Pacific raising money in public or private financings: Glycomimetics.

Med-tech firms raising money in public or private financings, including: Mirion Technologies, Xeltis.

Biopharmas raising money in public or private financings, including: Bavarian Nordic, Checkpoint, Esperas, Mymd, Nfl, Transcode, Verrica.

Hygea Medical Technology Co. Ltd. has completed a series D funding round to develop an integrated platform for interventional oncology procedures and expand globally.